Elevance Health Inc. (ELV) Misses Q2 EPS by 23c, Beats on Revenue; Offers FY25 EPS Guidance

Elevance Health Inc. (NYSE: ELV) reported Q2 EPS of $8.84, $0.23 worse than the analyst estimate of $9.07. Revenue for the quarter came in at $49.4 billion versus the consensus estimate of $48.14 billion.

GUIDANCE:

Elevance Health Inc. sees FY2025 EPS of $30.00, versus the consensus of $34.48.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• Boeing wins $2 billion satellite contract from DoW